Replies to post #10300 on Neovasc Inc (NVCN)

[Ryoko]

It seems the RS is because they want to stay listed on NASDQ, where they presumably would have an easier time issuing new shares. (Shares priced in the dollar range on NASDQ look far more attractive than sub-penny crap on OTC.) They will have to continue diluting to keep the lights on until they receive FDA approval which is going to take a while. With that in mind, the price is going down barring some significant news of progress (pending approval, for example) or some sort of buyout offer.

[AVALANCHE06]

By AS, are you referring to the Authorized Share Count? I think its inclusive all shares in a authorized total count. And now with those shares recouped and retainded by the company out of trading circulation so to speak. They may be reissued in the form of a dividend or utilized as a Forward Split or as a Special Dividend Offering to holding shareholders whenever in future at the company's desecration if circumstances have improved and is beneficial to both shareholders and the company. But that could be a long way down the road at a later date, or never happen.

All depends on how well conditions improve and sustain matters of what the co is involved with and managed during the recovering of how the RS may impact all aspects going forward if thats achieved I think.

Apparently the financials may not be as desired or instead of an RS they would do a share buyback in the least. So the RS is basically a paper shuffle cause things may not be looking as hot as all have been led to think.


GL